FDA Inspection 950938 — Weill Cornell Med College IRB
The FDA completed an inspection of Weill Cornell Med College IRB on December 11, 2015 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
IRB